Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

NOC

Northrop Grumman Stock Soaring – Will the Upsurge Persist?

This afternoon we watched Northrop Grumman rise 1.3% to a price of $477.32 per share. The Large-Cap Farm & Heavy Construction Machinery company is now trading -12.04% below its average target price of $542.66. Analysts have set target prices ranging from $477.0 to $621.45 per share for Northrop Grumman, and have given the stock an average rating of buy.

The stock has a very low short interest at 1.9%, and a short ratio of 1.88. The company's insiders own 0.23% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 84.8% of Northrop Grumman's shares being owned by this investor type.

Institutions Invested in Northrop Grumman

Date Reported Holder Percentage Shares Value
2025-03-31 State Street Corporation 9% 13,453,769 $6,421,820,452
2025-03-31 Vanguard Group Inc 9% 13,266,301 $6,332,337,286
2025-03-31 Blackrock Inc. 7% 10,508,165 $5,015,809,986
2025-03-31 Capital International Investors 6% 8,853,055 $4,225,784,585
2025-03-31 Wellington Management Group, LLP 4% 5,139,333 $2,453,132,186
2025-03-31 Morgan Stanley 3% 4,082,612 $1,948,732,822
2025-03-31 Geode Capital Management, LLC 2% 3,100,539 $1,479,964,816
2025-03-31 JPMORGAN CHASE & CO 2% 2,887,829 $1,378,433,012
2025-03-31 Bank of America Corporation 2% 2,768,008 $1,321,239,452
2025-03-31 Franklin Resources, Inc. 2% 2,624,381 $1,252,682,692

Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Northrop Grumman.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS